Steglatro
/
Steglatro (ertugliflozin) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated for the treatment of type 2 diabetes mellitus. It is taken as an oral tablet and is available by prescription. Patients are advised that Steglatro may increase the risk of urinary tract infections and should not be used in patients with severe renal impairment or end-stage renal disease.
FAQs about Steglatro
What should I do if I miss a dose?
If you miss a dose of Steglatro, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed dose. This information is provided in the Patient Counseling Information section of the label.
Can I stop taking Steglatro suddenly?
The label does not specifically warn against abrupt discontinuation of Steglatro. However, it is advisable to consult your prescriber before making any changes to your medication regimen. Your healthcare provider can provide guidance based on your individual health needs.
How should I store Steglatro?
Steglatro should be stored at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children. This storage information is typically included in the product labeling.
25
commonly-prescribed
medication.